(Q43946307)
Statements
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics (English)
Peter S Dragovich
Thomas J Prins
Ru Zhou
Edward L Brown
Fausto C Maldonado
Shella A Fuhrman
Leora S Zalman
Tove Tuntland
Caroline A Lee
Amy K Patick
David A Matthews
Thomas F Hendrickson
Maha B Kosa
Bo Liu
Minerva R Batugo
Jean-Paul R Gleeson
Sylvie K Sakata
Lijian Chen
Mark C Guzman
Rose Ann Ferre
Stephen T Worland